This February: RSV Peptide Pools & Arrays 20% OFF

Entering the second month of 2023 we announce a 20% discount on all our RSV catalog PepMix Peptide Pools and PepStar Peptide Microarrays. 

The surge of RSV cases in babies and children leading to high hospitalization rates is ongoing, requiring diagnostic and treatment intervention. Currently, there are no causative treatments for RSV infection and no active vaccines for children. 

For cellular immune response monitoring and T-cell epitope identification we want to point you in the direction of our RSV PepMix Peptide Pools. 

To map antibody epitopes and monitor humoral immune responses of RSV we refer you to our RSV PepStar Peptide Microarrays. 

Does your research involve other infections? Have a look at our growing variety of specific peptide tools for different infections or other clinical conditions.